APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drug Testing Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchDrug Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drug Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Drug Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug Testing market include Siemens Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Quest Diagnostics, Shimadzu, Quest Diagnostics, Laboratory Corporation of America MPD, KGAA Alere and Express Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Testing market.

Drug Testing Segment by Company

Siemens Healthcare

Thermo Fisher Scientific

Roche Diagnostics

Quest Diagnostics

Shimadzu

Quest Diagnostics

Laboratory Corporation of America MPD

KGAA Alere

Express Diagnostics

Drgerwerk AG & Co.

Drug Testing Segment by Type

Hair Sample

Breath Sample

Oral Fluid

Urine Sample

Others

Drug Testing Segment by Application

Personal Users

Workplace and Schools

Pain Management Centers

Criminal Justice System & Law Enforcement Agencies

Drug Testing Laboratories

Drug Treatment Centers

Hospitals

Drug Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Drug Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Testing key companies, revenue, market share, and recent developments.

3. To split the Drug Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Testing industry.

Chapter 3: Detailed analysis of Drug Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Testing Industry Trends Table 2. Drug Testing Industry Drivers Table 3. Drug Testing Industry Opportunities and Challenges Table 4. Drug Testing Industry Restraints Table 5. Global Drug Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Testing Revenue Share by Company (2021-2026) Table 7. Global Drug Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Testing Key Company Manufacturing Base & Headquarters Table 9. Global Drug Testing Company, Product Type & Application Table 10. Global Drug Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hair Sample Table 15. Significant Companies of Breath Sample Table 16. Significant Companies of Oral Fluid Table 17. Significant Companies of Urine Sample Table 18. Significant Companies of Others Table 19. Global Drug Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Drug Testing Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Drug Testing Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Drug Testing Sales Value Share by Type (2021-2026) Table 23. Global Drug Testing Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Personal Users Table 25. Significant Companies of Workplace and Schools Table 26. Significant Companies of Pain Management Centers Table 27. Significant Companies of Criminal Justice System & Law Enforcement Agencies Table 28. Significant Companies of Drug Testing Laboratories Table 29. Significant Companies of Drug Treatment Centers Table 30. Significant Companies of Hospitals Table 31. Global Drug Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Testing Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Drug Testing Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Drug Testing Sales Value Share by Application (2021-2026) Table 35. Global Drug Testing Sales Value Share by Application (2027-2032) Table 36. Global Drug Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Drug Testing Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Drug Testing Sales Value Share by Region (2021-2026) Table 39. Global Drug Testing Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Drug Testing Sales Value Share by Region (2027-2032) Table 41. Global Drug Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Drug Testing Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Drug Testing Sales Value Market Share by Country (2021-2026) Table 44. Global Drug Testing Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Drug Testing Sales Value Market Share by Country (2027-2032) Table 46. Siemens Healthcare Company Information Table 47. Siemens Healthcare Business Overview Table 48. Siemens Healthcare Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Siemens Healthcare Drug Testing Product Portfolio Table 50. Siemens Healthcare Recent Development Table 51. Thermo Fisher Scientific Company Information Table 52. Thermo Fisher Scientific Business Overview Table 53. Thermo Fisher Scientific Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Thermo Fisher Scientific Drug Testing Product Portfolio Table 55. Thermo Fisher Scientific Recent Development Table 56. Roche Diagnostics Company Information Table 57. Roche Diagnostics Business Overview Table 58. Roche Diagnostics Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Roche Diagnostics Drug Testing Product Portfolio Table 60. Roche Diagnostics Recent Development Table 61. Quest Diagnostics Company Information Table 62. Quest Diagnostics Business Overview Table 63. Quest Diagnostics Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Quest Diagnostics Drug Testing Product Portfolio Table 65. Quest Diagnostics Recent Development Table 66. Shimadzu Company Information Table 67. Shimadzu Business Overview Table 68. Shimadzu Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Shimadzu Drug Testing Product Portfolio Table 70. Shimadzu Recent Development Table 71. Quest Diagnostics Company Information Table 72. Quest Diagnostics Business Overview Table 73. Quest Diagnostics Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Quest Diagnostics Drug Testing Product Portfolio Table 75. Quest Diagnostics Recent Development Table 76. Laboratory Corporation of America MPD Company Information Table 77. Laboratory Corporation of America MPD Business Overview Table 78. Laboratory Corporation of America MPD Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Laboratory Corporation of America MPD Drug Testing Product Portfolio Table 80. Laboratory Corporation of America MPD Recent Development Table 81. KGAA Alere Company Information Table 82. KGAA Alere Business Overview Table 83. KGAA Alere Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. KGAA Alere Drug Testing Product Portfolio Table 85. KGAA Alere Recent Development Table 86. Express Diagnostics Company Information Table 87. Express Diagnostics Business Overview Table 88. Express Diagnostics Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Express Diagnostics Drug Testing Product Portfolio Table 90. Express Diagnostics Recent Development Table 91. Drgerwerk AG & Co. Company Information Table 92. Drgerwerk AG & Co. Business Overview Table 93. Drgerwerk AG & Co. Drug Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Drgerwerk AG & Co. Drug Testing Product Portfolio Table 95. Drgerwerk AG & Co. Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Drug Testing Product Image Figure 2. Global Drug Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hair Sample Image Figure 8. Breath Sample Image Figure 9. Oral Fluid Image Figure 10. Urine Sample Image Figure 11. Others Image Figure 12. Global Drug Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Drug Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Drug Testing Sales Value Share by Type (2021-2032) Figure 15. Personal Users Image Figure 16. Workplace and Schools Image Figure 17. Pain Management Centers Image Figure 18. Criminal Justice System & Law Enforcement Agencies Image Figure 19. Drug Testing Laboratories Image Figure 20. Drug Treatment Centers Image Figure 21. Hospitals Image Figure 22. Global Drug Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Drug Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Drug Testing Sales Value Share by Application (2021-2032) Figure 25. Global Drug Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Drug Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Drug Testing Sales Value (2021-2032) & (US$ Million) Figure 28. North America Drug Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Drug Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Drug Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Drug Testing Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Drug Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Drug Testing Sales Value (2021-2032) & (US$ Million) Figure 34. South America Drug Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Drug Testing Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Drug Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Drug Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Drug Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Drug Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Hair Sample
  • Breath Sample
  • Oral Fluid
  • Urine Sample
  • Others
Applications
  • Personal Users
  • Workplace and Schools
  • Pain Management Centers
  • Criminal Justice System & Law Enforcement Agencies
  • Drug Testing Laboratories
  • Drug Treatment Centers
  • Hospitals
Companies covered
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Quest Diagnostics
  • Shimadzu
  • Quest Diagnostics
  • Laboratory Corporation of America MPD
  • KGAA Alere
  • Express Diagnostics
  • Drgerwerk AG & Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Testing Market Dynamics
  1. 2.1 Drug Testing Industry Trends
  2. 2.2 Drug Testing Industry Drivers
  3. 2.3 Drug Testing Industry Opportunities and Challenges
  4. 2.4 Drug Testing Industry Restraints
3 Drug Testing Market by Company
  1. 3.1 Global Drug Testing Company Revenue Ranking in 2025
  2. 3.2 Global Drug Testing Revenue by Company (2021-2026)
  3. 3.3 Global Drug Testing Company Ranking (2024-2026)
  4. 3.4 Global Drug Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Testing Company Product Type and Application
  6. 3.6 Global Drug Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Testing Market by Type
  1. 4.1 Drug Testing Type Introduction
  2. 4.1.1 Hair Sample
  3. 4.1.2 Breath Sample
  4. 4.1.3 Oral Fluid
  5. 4.1.4 Urine Sample
  6. 4.1.5 Others
  7. 4.2 Global Drug Testing Sales Value by Type
  8. 4.2.1 Global Drug Testing Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Drug Testing Sales Value by Type (2021-2032)
  10. 4.2.3 Global Drug Testing Sales Value Share by Type (2021-2032)
5 Drug Testing Market by Application
  1. 5.1 Drug Testing Application Introduction
  2. 5.1.1 Personal Users
  3. 5.1.2 Workplace and Schools
  4. 5.1.3 Pain Management Centers
  5. 5.1.4 Criminal Justice System & Law Enforcement Agencies
  6. 5.1.5 Drug Testing Laboratories
  7. 5.1.6 Drug Treatment Centers
  8. 5.1.7 Hospitals
  9. 5.2 Global Drug Testing Sales Value by Application
  10. 5.2.1 Global Drug Testing Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Drug Testing Sales Value by Application (2021-2032)
  12. 5.2.3 Global Drug Testing Sales Value Share by Application (2021-2032)
6 Drug Testing Regional Value Analysis
  1. 6.1 Global Drug Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Testing Sales Value (2021-2032)
  7. 6.3.2 North America Drug Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Testing Sales Value (2021-2032)
  16. 6.6.2 South America Drug Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Testing Sales Value Share by Country, 2025 VS 2032
7 Drug Testing Country-level Value Analysis
  1. 7.1 Global Drug Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens Healthcare
  2. 8.1.1 Siemens Healthcare Company Information
  3. 8.1.2 Siemens Healthcare Business Overview
  4. 8.1.3 Siemens Healthcare Drug Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Healthcare Drug Testing Product Portfolio
  6. 8.1.5 Siemens Healthcare Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Drug Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Drug Testing Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Roche Diagnostics
  14. 8.3.1 Roche Diagnostics Company Information
  15. 8.3.2 Roche Diagnostics Business Overview
  16. 8.3.3 Roche Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Diagnostics Drug Testing Product Portfolio
  18. 8.3.5 Roche Diagnostics Recent Developments
  19. 8.4 Quest Diagnostics
  20. 8.4.1 Quest Diagnostics Company Information
  21. 8.4.2 Quest Diagnostics Business Overview
  22. 8.4.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Quest Diagnostics Drug Testing Product Portfolio
  24. 8.4.5 Quest Diagnostics Recent Developments
  25. 8.5 Shimadzu
  26. 8.5.1 Shimadzu Company Information
  27. 8.5.2 Shimadzu Business Overview
  28. 8.5.3 Shimadzu Drug Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shimadzu Drug Testing Product Portfolio
  30. 8.5.5 Shimadzu Recent Developments
  31. 8.6 Quest Diagnostics
  32. 8.6.1 Quest Diagnostics Company Information
  33. 8.6.2 Quest Diagnostics Business Overview
  34. 8.6.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quest Diagnostics Drug Testing Product Portfolio
  36. 8.6.5 Quest Diagnostics Recent Developments
  37. 8.7 Laboratory Corporation of America MPD
  38. 8.7.1 Laboratory Corporation of America MPD Company Information
  39. 8.7.2 Laboratory Corporation of America MPD Business Overview
  40. 8.7.3 Laboratory Corporation of America MPD Drug Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Laboratory Corporation of America MPD Drug Testing Product Portfolio
  42. 8.7.5 Laboratory Corporation of America MPD Recent Developments
  43. 8.8 KGAA Alere
  44. 8.8.1 KGAA Alere Company Information
  45. 8.8.2 KGAA Alere Business Overview
  46. 8.8.3 KGAA Alere Drug Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 KGAA Alere Drug Testing Product Portfolio
  48. 8.8.5 KGAA Alere Recent Developments
  49. 8.9 Express Diagnostics
  50. 8.9.1 Express Diagnostics Company Information
  51. 8.9.2 Express Diagnostics Business Overview
  52. 8.9.3 Express Diagnostics Drug Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Express Diagnostics Drug Testing Product Portfolio
  54. 8.9.5 Express Diagnostics Recent Developments
  55. 8.10 Drgerwerk AG & Co.
  56. 8.10.1 Drgerwerk AG & Co. Company Information
  57. 8.10.2 Drgerwerk AG & Co. Business Overview
  58. 8.10.3 Drgerwerk AG & Co. Drug Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Drgerwerk AG & Co. Drug Testing Product Portfolio
  60. 8.10.5 Drgerwerk AG & Co. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst